Rapt Therapeutics Inc (RAPT)

03:32 AM

Rapt Therapeutics (NASDAQ:RAPT) Receives Consensus Rating of “Hold” from Analysts - Defense World

03:32 AM

Jul 22, 2025

What drives RAPT Therapeutics Inc. stock priceAccelerated financial growth - Autocar Professional

Jul 22, 2025

Jul 22, 2025

What analysts say about RAPT Therapeutics Inc. stockFree Stock Selection - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

RAPT Therapeutics: LifeSci Capital initiates Outperform with $31 PT. - AInvest

Jul 22, 2025

Jul 22, 2025

RAPT Therapeutics Inc. Stock Analysis and ForecastExplosive capital gains - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What makes RAPT Therapeutics Inc. stock price move sharplyFree Access to Investment Community - Newser

Jul 22, 2025

Jul 19, 2025

Is RAPT Therapeutics Inc. a good long term investmentHigh-performance investment picks - jammulinksnews.com

Jul 19, 2025

Jul 15, 2025

How RAPT Therapeutics Inc. stock performs during market volatilityTop Performer Shortlist - Newser

Jul 15, 2025

Jul 15, 2025

Why RAPT Therapeutics Inc. stock attracts strong analyst attentionSafe Entry High Exit Alerts - Newser

Jul 15, 2025

Jul 15, 2025

Rapt Therapeutics (RAPT) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Jul 15, 2025

Jul 15, 2025

RAPT Therapeutics Explodes 20%—What's Fueling the Surge? - AInvest

Jul 15, 2025

Jul 15, 2025

RAPT Therapeutics Soars 24%—What’s Fueling the Breakout? - AInvest

Jul 15, 2025

Jul 15, 2025

Best Momentum Stocks to Buy for July 15th - TradingView

Jul 15, 2025

Jul 15, 2025

Does Rapt Therapeutics (RAPT) Have the Potential to Rally 183.83% as Wall Street Analysts Expect? - Yahoo Finance

Jul 15, 2025

Jul 14, 2025

HC Wainwright Analysts Decrease Earnings Estimates for RAPT - Defense World

Jul 14, 2025

Jul 12, 2025

HC Wainwright Forecasts Strong Price Appreciation for Rapt Therapeutics (NASDAQ:RAPT) Stock - Defense World

Jul 12, 2025

Jul 12, 2025

Rapt Therapeutics (NASDAQ:RAPT) Price Target Raised to $27.00 - Defense World

Jul 12, 2025

Jul 11, 2025

H.C. Wainwright Maintains RAPT Therapeutics(RAPT.US) With Buy Rating, Cuts Target Price to $27 - 富途牛牛

Jul 11, 2025

Jul 08, 2025

RAPT Therapeutics Unveils Plans for RPT904 Development - TipRanks

Jul 08, 2025

Jun 28, 2025

Rapt Therapeutics (NASDAQ:RAPT) Given Average Rating of “Hold” by Analysts - Defense World

Jun 28, 2025

Jun 23, 2025

RAPT Therapeutics Expands Board with New Appointments - TipRanks

Jun 23, 2025

Jun 18, 2025

Wall Street Analysts Predict a 282.65% Upside in Rapt Therapeutics (RAPT): Here's What You Should Know - Yahoo Finance

Jun 18, 2025

Jun 17, 2025

RAPT Therapeutics Executes 1-for-8 Reverse Stock Split - TipRanks

Jun 17, 2025

Jun 16, 2025

RAPT Therapeutics (RAPT) Trading Halted as News Awaits Release | RAPT Stock News - GuruFocus

Jun 16, 2025

Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025

Jun 14, 2025

Rapt Therapeutics announces effective date for 1-for-8 reverse stock split - Yahoo Finance

Jun 14, 2025

Jun 13, 2025

# RAPT Therapeutics to implement 1-for-8 reverse stock split By Investing.com - Investing.com South Africa

Jun 13, 2025

Jun 13, 2025

RAPT Finalizes Reverse Split Plan; 1-for-8 Ratio Effective June 16, 2025 - Nasdaq

Jun 13, 2025

Jun 13, 2025

RAPT Therapeutics Shares to Start Trading on a Split-Adjusted Basis Tuesday - marketscreener.com

Jun 13, 2025

Jun 13, 2025

RAPT Therapeutics Announces Effective Date For 1-For-8 Reverse Stock Split - MarketScreener

Jun 13, 2025

Jun 13, 2025

RAPT Therapeutics Announces Reverse Stock Split Effective June 2025 | RAPT Stock News - GuruFocus

Jun 13, 2025

Jun 13, 2025

# RAPT Therapeutics to implement 1-for-8 reverse stock split - Investing.com

Jun 13, 2025

Jun 13, 2025

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split - GlobeNewswire

Jun 13, 2025